June 12, 2025

Smoking Cessation Drugs Show No Birth Risk

A large multinational cohort study found no increased risk of major congenital malformations associated with nicotine replacement therapy, varenicline, or bupropion use during early pregnancy.

Conexiant

June 09, 2025

New Fixed-Dose RSV Antibody Approved

The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.

Conexiant

June 04, 2025

Big Tobacco's Medical Research Infiltrates Journals

Investigation reveals tobacco-funded studies appear in top medical journals despite industry bans, as companies invest billions in pharmaceutical subsidiaries.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 22, 2025

FDA to Rethink COVID Booster Formula

FDA advisers to vote on whether 2025–2026 COVID vaccines should target JN.1 descendants like LP.8.1 amid rising uncertainty over dominant strains.

Reuters

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 20, 2025

New COVID Shot: LP.8.1?

FDA advisers to consider recommending COVID-19 vaccine for 2025-2026 season to target LP.8.1 subvariant.

Reuters

May 20, 2025

No Trials, No Boosters, Says FDA

FDA to require new clinical trials for COVID booster approval in healthy Americans under 65, limiting fall availability to high-risk groups.

Reuters